• Genetic Diagnostics Find Common Ground Between ME/CFS, Long COVID

    Jun 05 | Diagnostics World | PrecisionLife's new diagnostic approach is addressing a critical gap in complex chronic disease detection by targeting two genetically related conditions that share remarkable similarities. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are not just clinically similar—they're genetically connected, with researchers identifying nine genes common to both disease populations. More

  • After More Than Four Decades, a Third Subtype of Castleman Disease Found

    Jun 03 | Diagnostics World | A new subtype of Castleman disease has been identified, the first such major discovery in 45 years. While it remains unclear how many individuals stand to benefit, this is a “hugely important” development for the proportion of patients who fit neither the “unicentric” nor “multicentric” criteria long used to describe the symptoms and disease experience. More

  • Follow the Money: Deepull’s Diagnostic System, Gestalt Expands Pathology Platform, More

    May 30 | Diagnostics World | iCAD announced a collaboration with Microsoft to include a set of AI-powered mammography solutions; Revvity has launched its new IDS i20 analytical random access platform from EUROIMMUN; and more. More

  • Microsoft, iCAD Collaboration, Revvity Launches New Platform, More

    May 29 | Diagnostics World | iCAD announced a collaboration with Microsoft to include a set of AI-powered mammography solutions; Revvity has launched its new IDS i20 analytical random access platform from EUROIMMUN; and more. More

  • Smart Bandage for Monitoring Chronic Wounds Moves from Mice to Humans

    May 27 | Diagnostics World | Parallel developments in wearable sensors, microfluidics, and machine learning have enabled the first-time use of a “smart bandage” in 20 human patients with chronic wounds. The latest version of the bandage, referred to as iCares, was showcased in a new study where fresh fluid from injured tissue was continually sampled to classify wound severity and healing potential. More

  • The Diagnostic Dilemma: Addressing Errors in Modern Healthcare

    May 23 | Diagnostics World | Diagnostic errors remain a persistent and costly challenge in healthcare worldwide, leading to significant patient harm and financial burden. Despite advances in medical technology and research, these errors—missed, delayed, or incorrect diagnoses—cause thousands of preventable deaths and billions in healthcare costs each year. More

  • Applying Genomics Beyond Cancer

    May 16 | Diagnostics World | Genomics has led to phenomenal scientific and medical advances over the last several decades, especially in cancer care. This progress can be seen not only in personalized therapies and drug development, but also in the ability to use biomarkers to identify the right drug for the right patient at the right time. More

  • Comparison of AI Digital Pathology Tools Finds Means to Measure Performance

    May 15 | Diagnostics World | In a research project comparing the performance of 10 digital pathology tools capable of evaluating HER2 status from a common set of about 1,100 breast cancer samples, a key finding was the high level of agreement between their results and those of expert human pathologists—at least when the tumor marker was highly expressed. More

  • Protecting Clinical Labs in the Crossfire of Health Policy Debates

    May 13 | Diagnostics World | For diagnostic labs, 2025 is a “big, complicated year” that began with a milestone “win” for laboratories when a U.S. District Court decision vacated a Food and Drug Administration (FDA) final rule that would have regulated all laboratory-developed tests (LDTs) as medical devices. Despite that win, there is no shortage of concerns and challenges facing the industry, including unknowns about the final shape of the federal reconciliation package on Capitol Hill. More

  • ‘Better Stethoscope’ Could be First Step in Diagnosing Heart Valve Disease

    May 08 | Diagnostics World | The stethoscope, despite being more than 200 years old, is not an easily retired diagnostic device. It remains symbolic of the medical profession, even if many physicians no longer wear them and those that do are not particularly good at using them. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more